We recently published a list of Top 20 Falling Stocks with Unusual Volume. In this article, we are going to take a look at ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Novo Nordisk is set to benefit from a $150B market by 2030, with strong earnings potential and a favorable 14x forward P/E.

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Novo Nordisk said on Monday all eligible cash-paying customers in the United States can buy its weight-loss drug Wegovy at a ...

FDA and Novo Nordisk warn about counterfeit Ozempic in the U.S. with fake serial numbers, posing risks due to unknown ...

Pfizer halted development of its weight-loss pill, danuglipron, after liver injury concerns surfaced during trials, impacting ...

Eli Lilly's robust sales for Mounjaro and Zepbound along with its positive outlook for 2025 also work in its favor. Click ...

It has been a tough period for Novo Nordisk shareholders. In the summer of 2024 ... “We’re […] Denmark has officially added a new national flag day to mark the 18th birthday of Princess Isabella. The ...

After some tough weeks, the Danish stock market opened poorly following the Easter holidays. The C25 index fell by 1.7% in ...